Rallis India reverses seed and pricing guidance; Q1 profit masked by one-off
Q1 PAT rose 31% but included a one-off; management now sees cotton flat and pricing power weak.
The numbers
- Q1 PAT ₹125 cr, up 31% YoY but includes a one-off provision reversal.
- B2B export volumes fell 26%.
- Seed revenue grew only 6%.
- Revenue rose 7% to ₹1,022 cr.
- Working capital stretched by 15-20 days.
Management's story
- Cotton seeds are unlikely to grow this year, a reversal from earlier high double-digit forecast.
- April price increases were only partially passed on; most growth must come from volume.
- FY27 domestic crop protection growth guided at 6%-8%.
- Five-year EBITDA margin improvement of 500 bps reiterated but contingent on volume recovery.
- Management wants clearer visibility by mid-August before offering a revised seed outlook.
“In seeds, we have already factored in that the cotton business is unlikely to grow this year.”
— Dr. Gyanendra Shukla, MD & CEO
Where they diverge
The numbers show a seasonally decent quarter, but the narrative of accelerating growth is fraying. Seed revenue of 6% is a far cry from the high double-digit guidance given just six months ago. Pricing power, touted as fully intact in April, is now partial or absent. Export demand remains weak. The 500-bps margin improvement target, a key investor thesis, rests entirely on volume recovery in a market that has not yet demonstrated it.
The full read
Rallis India's Q1 numbers flatter, but the real story is a double reversal in guidance. PAT jumped 31% to ₹125 crore, aided by a provision reversal. Revenue rose 7% to ₹1,022 crore. But behind those figures, management has walked back two key assumptions. Cotton seeds, forecast as the highest-growth crop in January, are now 'unlikely to grow.' Seed revenue managed just 6%. Pricing power, declared intact in April, is now partial or absent. 'In some areas, we passed on the full cost increase, and in others, only partial or none,' CEO Dr. Gyanendra Shukla said. Export volumes dropped 26%, and working capital stretched by 15-20 days. The five-year target of 500 bps EBITDA margin improvement remains on the table, but only if volume delivers what pricing cannot. Management has asked investors to wait until mid-August for clarity. Until then, the FY27 margin roadmap remains a guess.
What we're watching
- Mid-August commentary on crop protection volumes for a near-term demand signal.
- Seed revenue trajectory in Q2: will single-digit growth hold or slip further?
- Export volume recovery or further decline in B2B segment.
- Working capital days: any reduction from current stretched levels.